Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir-Reference-Cited by-同舟云学术

Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir

Published:2024-05-24 Issue:7 Volume:13 Page:1703-1713
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Cuesta Genoveva,Cacho Judit,Cucchiari David,Herrera Sabina,Sempere Abiu,Akter Tabassum,Villasante Anna,Garrido Miriam,Cofan Frederic,Diekmann Fritz,Soriano Alex,Marcos Maria Angeles,Bodro Marta^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-024-00991-6.pdf

Reference21 articles.

1. World Health Organization. COVID-19 Epidemiological update. Emergency Situational Updates, p. Edition 161 COVID-19 Epidemiological update—(24 November 2023). Edition 161. Emergency Situational Updates. 2023. Available from: https://www.who.int/publications/m/item/covid-19-epidemiological-update-24-november-2023. [cited 2024 Jan 10]

2. Caillard S, Chavarot N, Francois H, Matignon M, Greze C, Kamar N, et al. Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021;21(3):1295–303.

3. Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med [Internet]. 2020;383(23):2291–3. Available from: https://pubmed.ncbi.nlm.nih.gov/33176080/. [cited 2023 May 30]

4. Niess H, Börner N, Muenchhoff M, Khatamzas E, Stangl M, Graf A, et al. Liver transplantation in a patient after COVID-19—rapid loss of antibodies and prolonged viral RNA shedding. Am J Transplant [Internet]. 2021;21(4):1629–32. Available from: https://pubmed.ncbi.nlm.nih.gov/33047475/. [cited 2023 May 30]

5. Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2022.